A61K 2039/54
Medicinal preparations containing antigens or antibodies: characterised by the route of administration
Official title: {characterised by the route of administration}
A61K2039/54 (Medicinal preparations containing antigens or antibodies: characterised by the route of administration) appears on 4,021 US grants and 7,981 published applications in this corpus.
Search patents in A61K- Granted patents
- 4,021
- Published applications
- 7,981
- Assignees
- 2,767
- Inventors
- 13,849
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 7 | 0 |
| 1977 | 2 | 0 |
| 1978 | 1 | 0 |
| 1979 | 1 | 0 |
| 1980 | 4 | 0 |
| 1981 | 4 | 0 |
| 1982 | 6 | 0 |
| 1983 | 2 | 0 |
| 1984 | 1 | 0 |
| 1985 | 6 | 0 |
| 1986 | 4 | 0 |
| 1987 | 7 | 0 |
| 1988 | 4 | 0 |
| 1989 | 6 | 0 |
| 1990 | 1 | 0 |
| 1991 | 7 | 0 |
| 1992 | 8 | 0 |
| 1993 | 5 | 0 |
| 1994 | 0 | 0 |
| 1995 | 9 | 0 |
| 1996 | 12 | 0 |
| 1997 | 29 | 0 |
| 1998 | 40 | 0 |
| 1999 | 38 | 0 |
| 2000 | 45 | 0 |
| 2001 | 31 | 18 |
| 2002 | 44 | 97 |
| 2003 | 42 | 127 |
| 2004 | 39 | 166 |
| 2005 | 42 | 155 |
| 2006 | 54 | 136 |
| 2007 | 45 | 114 |
| 2008 | 46 | 156 |
| 2009 | 68 | 171 |
| 2010 | 70 | 214 |
| 2011 | 81 | 217 |
| 2012 | 103 | 227 |
| 2013 | 104 | 202 |
| 2014 | 135 | 229 |
| 2015 | 168 | 258 |
| 2016 | 201 | 414 |
| 2017 | 230 | 450 |
| 2018 | 279 | 424 |
| 2019 | 261 | 443 |
| 2020 | 280 | 459 |
| 2021 | 294 | 492 |
| 2022 | 270 | 526 |
| 2023 | 219 | 582 |
| 2024 | 245 | 595 |
| 2025 | 267 | 611 |
| 2026 | 154 | 498 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Systems and methods for administering dermal and transdermal immunotherapy topical application compounds to animals6 Oct 2026US 12,751,998 B2Allibre Animal LLC
- HERV-K (HML-2) Env analog fusion proteins for antigen specific immunotherapy and methods of use29 Sep 2026US 12,747,270 B2Twilight Bioscience, Inc.
- Construction of chimeric antigen receptor targeting CD20 antigen and activity identification of engineered T cells thereof29 Sep 2026US 12,747,279 B2Abelzeta Inc.
- Compositions for the treatment of rheumatoid arthritis and methods of using same29 Sep 2026US 12,747,487 B2Regeneron Pharmaceuticals, Inc.
- Immunomodulatory and oncolytic minicells and methods of use22 Sep 2026US 12,741,010 B2Vaxiion Therapeutics, Inc.
- Lipid nanoparticle for delivering nucleic acid drug, and preparation method therefor and use thereof8 Oct 2026US 2026/0306419 A1Cansino (Shanghai) Biological Research Co., Ltd.
- Development of carbohydrate-based anti-salmonella vaccines8 Oct 2026US 2026/0306602 A1Board of Trustees of Michigan State University
- Mucosal vaccines against tuberculosis8 Oct 2026US 2026/0306604 A1University of Houston System
- Inhaled adenovirus vector vaccine, preparation method therefor and use thereof8 Oct 2026US 2026/0306605 A1Cansino Biologics Inc.
- Pharmaceutical Composition for Vaccination against Cytomegalovirus Infections8 Oct 2026US 2026/0306606 A1Instar Technologies A.S.
Most cited
By later US patents
- Method of potentiating an immune response425US 5,075,109 ASouthern Research Institute · 1991
- Dispersible antibody compositions and methods for their preparation and use351US 6,019,968 AInhale Therapeutic Systems · 2000
- Frozen piercing implements and methods for piercing a substrate284US 8,784,385 B2The Invention Science Fund I, LLC · 2014
- Polymerized liposomes targeted to M cells and useful for oral or mucosal drug delivery242US 6,060,082 AMassachusetts Institute of Technology · 2000
- Receptor specific transepithelial transport of therapeutics240US 6,485,726 B1Brandeis University · 2002